Tani K, Fujii H, Takahashi K, Kodo H, Asano S, Takaku F, Miwa S
Department of Internal Medicine, University of Tokyo, Japan.
Am J Hematol. 1989 Feb;30(2):97-103. doi: 10.1002/ajh.2830300209.
The erythrocyte enzyme activities in twenty-six cases of myelodysplastic syndromes were determined. There were remarkably abnormal levels in seven cases; namely, four cases showed increased hexokinase activity, three cases showed increased pyruvate kinase activity, and two cases showed increased adenosine deaminase activity. Among these, one case with elevated pyruvate kinase activity showed the novel expression of M2-type pyruvate kinase activity, in addition to the R-type pyruvate kinase activity normally found in erythrocytes. Southern blotting of peripheral leucocyte DNA revealed only an amplified PK-LR genome, which derived from the chromosomal abnormality of a 1;7 translocation. The mechanism responsible for switching M2-type to R-type during erythroid maturation was considered to be partially disrupted in this case.
测定了26例骨髓增生异常综合征患者的红细胞酶活性。7例患者的酶活性水平显著异常;具体而言,4例己糖激酶活性升高,3例丙酮酸激酶活性升高,2例腺苷脱氨酶活性升高。其中,1例丙酮酸激酶活性升高的患者除了红细胞中正常存在的R型丙酮酸激酶活性外,还出现了新型的M2型丙酮酸激酶活性表达。外周血白细胞DNA的Southern印迹分析仅显示PK-LR基因组扩增,其源于1;7易位的染色体异常。在这种情况下,红细胞成熟过程中M2型向R型转换的机制被认为部分受到破坏。